Johnlee Pharmaceuticals Private Limited

Johnlee Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U46300MH2011PTC216610 Incorporated 25 April 2011 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹73.78 Cr
▲ 39% YoY
Net profit · FY 2024
₹4.19 Cr
Net margin 5.7%
EBITDA · FY 2024
₹6.97 Cr
EBITDA margin 9.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings

About Johnlee Pharmaceuticals Private Limited

Data last updated:

Johnlee Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46300MH2011PTC216610. Its GSTIN is 27AACCJ5804C1ZX (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Jsk Medicare Private Limited. It is led by directors Dilip Kishanlal Jain and Girish Kishanlal Jain.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 6 2nd Floor Om Shanti Co – Op. Hsg. Soc. 42/44 Babu Genu Road Kalbadevi, Mumbai, Maharashtra, India – 400002.

As per the financials filed for FY 2024, the company reported a revenue of ₹73.78 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹4.19 Cr (net margin 5.7%) and EBITDA of ₹6.97 Cr (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 20% over five years.

The company is associated with 1 brand: Johnlee Pharmaceuticals. As per MCA filings, the company has open charges of ₹6 Cr on record. Court records list 23 cases involving the company, including 8 filed by the company and 15 filed against it; 15 cases are pending.

Johnlee Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0037482). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website johnleeindia.com.

Company details

CIN U46300MH2011PTC216610
Registration Number 216610
Incorporation Date 25 April 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0037482

CIN history

Johnlee Pharmaceuticals has one previous CIN (Corporate Identification Number): U52399MH2011PTC216610. The current CIN is U46300MH2011PTC216610, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U46300MH2011PTC216610Current
U52399MH2011PTC216610Previous

Recognitions & Rankings of Johnlee Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-19-0037482

Contact details

Johnlee Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is johnleeindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. 6 2nd Floor Om Shanti Co – Op. Hsg. Soc. 42/44 Babu Genu Road Kalbadevi, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Johnlee Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Johnlee Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Johnlee Pharmaceuticals operates one associated brand: Johnlee Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and marketing of pharmaceutical formulations, including tablets, capsules, and injections in India.johnleeindia.com

Business activity

The main business activity of Johnlee Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Johnlee Pharmaceuticals Private Limited, buy the company report.

Financials of Johnlee Pharmaceuticals Private Limited

FY 2024 filings available

Johnlee Pharmaceuticals Private Limited reported revenue of ₹73.78 Cr (up 39% YoY) for FY 2024.

Revenue · FY 2024
₹73.78 Cr ▲ 39%
Net profit · FY 2024
₹4.19 Cr margin 5.7%
EBITDA · FY 2024
₹6.97 Cr margin 9.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 18%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 28%
5 years · compounded
▲ 35%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 39% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹73.78 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.97 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.19 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.5%
Net Profit Margin5.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Johnlee Pharmaceuticals Private Limited, buy the company report.

Board of directors of Johnlee Pharmaceuticals Private Limited

Johnlee Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dilip Kishanlal JainDirector25 Apr 201115 Years 6 MonthsCurrent
Girish Kishanlal JainDirector25 Apr 201115 Years 6 MonthsCurrent

Auditor

Johnlee Pharmaceuticals Private Limited is audited by JAIN & SANCHETI for the financial year 2024.

Auditor firmFinancial yearFirm registration number
JAIN & SANCHETIFY 2024113786W

Shareholding

The shareholding of Johnlee Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Johnlee Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹6.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Aug 2018100208232Others₹6 CrOpen

To see the full charge records of Johnlee Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

Johnlee Pharmaceuticals Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 897 overdue payments to 51 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 51)

SupplierAmount dueDue sinceReported on
Oscar Remedies Pvt Ltd
United Bioceuticals Private Limited
Biodeal Pharmaceuticals Limited
Cian Healthcare Limited
Synokem Lifesciences Private Limited

To see the full MSME payment records of Johnlee Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Johnlee Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AACCJ5804C1ZXMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Johnlee Pharmaceuticals Private Limited, buy the company report.

Recent activity

Johnlee Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Dilip Kishanlal Jain was appointed as Director on 25 Apr 2011.

AGM
Johnlee Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Johnlee Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others of Rs. 600.00 Lakh registered on 27 Aug 2018 with Charge ID 100208232 was modified on 02 Feb 2023.
Charges
A charge with Others amounted to Rs. 600.00 Lakh with Charge ID 100208232 was registered on 27 Aug 2018.
Appointed
Dilip Kishanlal Jain was appointed as Director.
Appointed
Girish Kishanlal Jain was appointed as Director.
Incorporation
25 Apr 2011
Johnlee Pharmaceuticals Private Limited was registered on 25 Apr 2011 with Roc Mumbai & aged 15 years 6 months as per MCA records.

Frequently asked questions

Johnlee Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2011 (15+ years old) and is registered under CIN U46300MH2011PTC216610.

Johnlee Pharmaceuticals has 2 current directors:

The latest financial statements of Johnlee Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Johnlee Pharmaceuticals is 27AACCJ5804C1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Johnlee Pharmaceuticals is U46300MH2011PTC216610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Johnlee Pharmaceuticals has 23 court cases on record: 8 filed by the company and 15 filed against it. 15 are pending. Most are in the high courts.

Johnlee Pharmaceuticals was incorporated on 25 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Dilip Kishanlal Jain was appointed as Director on 25 Apr 2011. Girish Kishanlal Jain was appointed as Director on 25 Apr 2011.

Yes, Johnlee Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0037482).

Johnlee Pharmaceuticals has 13 MSME Form 1 returns on record between 2019 and 2024, listing 897 overdue payments to 51 micro and small suppliers. The latest return was filed on 09 May 2024.

Johnlee Pharmaceuticals can be reached through the website johnleeindia.com. Its registered office is in Mumbai, Maharashtra, India.